Literature DB >> 8206081

T-cell receptor gene rearrangements in lymphoid and non-lymphoid leukaemias.

S Casares1, J M Rodriguez, A Martin, A Parrado.   

Abstract

Rearrangements of delta-, tau-, and beta- T-cell receptor (TcR) chain genes were analysed in 64 haematologic malignancies comprising T- and B-lineage acute lymphoblastic leukaemias (ALL), B-chronic lymphocytic leukaemias (CLL), acute myeloid leukaemias (AML) and acute undifferentiated leukaemias AUL). The TcR genes were rearranged in 5/6 T-ALL. In non-T-leukaemias the frequency of TcR gene rearrangements was higher in B-lineage ALL (8/11), although they were all detected in B-CLL (5/29), AML (1/16) and AUL (2/4). Immunoglobulin (Ig) gene rearrangements were observed in 1/6 T-ALL and 2/14 AML. The analysis of these gene configurations has a diagnostic application since it allows the definition of the clonality of malignant proliferation and although they are not lineage specific such configurations represent a further parameter to evaluate, together with the immunophenotype and morphology, in the assignment or exclusion of the differentiation lineage of the haematologic malignancies.

Entities:  

Mesh:

Year:  1994        PMID: 8206081     DOI: 10.1111/j.1365-2362.1994.tb00976.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Acute lymphoblastic leukaemia: correlation between morphological/immunohistochemical and molecular biological findings in bone marrow biopsy specimens.

Authors:  S M Kröber; A Greschniok; E Kaiserling; H P Horny
Journal:  Mol Pathol       Date:  2000-04

2.  Translocation t(2;14)(p13;q32) in a case of Ph+ acute lymphoblastic leukemia.

Authors:  Lily Kerketta; Babu Rao Vundinti; Kanjaksha Ghosh
Journal:  Indian J Hum Genet       Date:  2007-09

3.  Dogs with Acute Myeloid Leukemia Have Clonal Rearrangements in T and B Cell Receptors.

Authors:  Tracy Stokol; Gabrielle A Nickerson; Martha Shuman; Nicole Belcher
Journal:  Front Vet Sci       Date:  2017-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.